N-[2-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-2-methylpropyl]-5-(5-methyl-1,2,4-oxadiazol-3-yl)pyridine-3-carboxamide;2-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]-2-methylpropan-1-amine;5-(5-methyl-1,2,4-oxadiazol-3-yl)pyridine-3-carboxylic acid
C44H42ClFN10O5S2 — CID 159075127
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[2-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-2-methylpropyl]-5-(5-methyl-1,2,4-oxadiazol-3-yl)pyridine-3-carboxamide;2-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]-2-methylpropan-1-amine;5-(5-methyl-1,2,4-oxadiazol-3-yl)pyridine-3-carboxylic acid
N-[2-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-2-methylpropyl]-5-(5-methyl-1,2,4-oxadiazol-3-yl)pyridine-3-carboxamide;2-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]-2-methylpropan-1-amine;5-(5-methyl-1,2,4-oxadiazol-3-yl)pyridine-3-carboxylic acid (PubChem CID 159075127) has the molecular formula C44H42ClFN10O5S2 and a molecular weight of 909.47 g/mol. Its IUPAC name is N-[2-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-2-methylpropyl]-5-(5-methyl-1,2,4-oxadiazol-3-yl)pyridine-3-carboxamide;2-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]-2-methylpropan-1-amine;5-(5-methyl-1,2,4-oxadiazol-3-yl)pyridine-3-carboxylic acid.
Molecular Properties
| Compound Name | N-[2-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-2-methylpropyl]-5-(5-methyl-1,2,4-oxadiazol-3-yl)pyridine-3-carboxamide;2-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]-2-methylpropan-1-amine;5-(5-methyl-1,2,4-oxadiazol-3-yl)pyridine-3-carboxylic acid |
|---|---|
| PubChem CID | 159075127 |
| Molecular Formula | C44H42ClFN10O5S2 |
| Molecular Weight | 909.47 g/mol |
| Exact Mass | 908.25 |
| IUPAC Name | N-[2-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-2-methylpropyl]-5-(5-methyl-1,2,4-oxadiazol-3-yl)pyridine-3-carboxamide;2-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]-2-methylpropan-1-amine;5-(5-methyl-1,2,4-oxadiazol-3-yl)pyridine-3-carboxylic acid |
| SMILES | CC(C)(CN)c1nc(-c2ccc(F)cc2)cs1.Cc1nc(-c2cncc(C(=O)NCC(C)(C)c3nc(-c4ccc(Cl)cc4)cs3)c2)no1.Cc1nc(-c2cncc(C(=O)O)c2)no1 |
| InChI | InChI=1S/C22H20ClN5O2S.C13H15FN2S.C9H7N3O3/c1-13-26-19(28-30-13)15-8-16(10-24-9-15)20(29)25-12-22(2,3)21-27-18(11-31-21)14-4-6-17(23)7-5-14;1-13(2,8-15)12-16-11(7-17-12)9-3-5-10(14)6-4-9;1-5-11-8(12-15-5)6-2-7(9(13)14)4-10-3-6/h4-11H,12H2,1-3H3,(H,25,29);3-7H,8,15H2,1-2H3;2-4H,1H3,(H,13,14) |
| InChIKey | KADOXOYQKCYGSO-UHFFFAOYSA-N |
| XLogP | 9.25 |
| TPSA | 221.82 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 15 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 63 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 909.47 |
| LogP ≤ 5 | 9.25 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 15 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159075127 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.